Skip to content

Antimicrobial use software for hospital stewardship teams compared on data needs and price

Which tools count antibiotic days of therapy and report to NHSN, what data they need, how they are priced, and the resistance numbers a stewardship committee still has to put next to them.

8 min read

Antibiogram Builder
Synthetic sample dataset
Parsed in this browser, never uploaded.

under 40 40 to 59 60 to 74 75 to 89 90 and over n<30, below the reporting threshold n/t, not tested on this panel

Antimicrobial use software counts how much antibiotic a hospital gives, usually as days of therapy per 1,000 days present, and reports it to the NHSN Antimicrobial Use Option, which turns it into a standardized antimicrobial administration ratio (SAAR). In the US the choice is between the stewardship module of your EHR and a surveillance platform such as Sentri7, VigiLanz or TheraDoc. All of them need electronic administration data, and none of the platforms publishes a price.

This comparison is for the stewardship pharmacist, infectious diseases physician or quality lead at a community hospital who has to show the committee and CMS that antibiotic use is measured. It covers what each option does, what it needs, how it is sold, and the part of the stewardship report that use software does not produce at all.

What antimicrobial use software measures

The core measure is days of therapy. One patient receiving any dose of a given antibiotic on a calendar day counts as one day of therapy for that drug, so two drugs on the same day count as two. The NHSN definition counts administrations recorded in the eMAR or barcode system, not orders, and divides by days present, which counts each patient on each unit for each calendar day they were there. That denominator is why a spreadsheet built from census midnight counts never matches the NHSN figure.

From those counts the software produces three things a committee uses. Unit level rates show where broad-spectrum use is concentrated. Agent group trends show whether a guideline change moved prescribing. The SAAR compares observed use against a national model for similar locations, which is the number a board and an accreditation surveyor recognize.

  • Days of therapy per 1,000 days present, by agent, agent group and unit
  • NHSN AU Option files in the CDA format the CDC specifies
  • SAAR by location type, for broad-spectrum hospital onset, community onset, anti-MRSA and other groups
  • Trend views around a guideline, order set or formulary change

Why hospitals are buying it now

Since the 2024 reporting period, CMS Promoting Interoperability requires eligible hospitals and critical access hospitals to report to the NHSN Antimicrobial Use and Resistance surveillance measure, or claim an exclusion. Submission needs a vendor whose AU output has been validated by the CDC, and the CDC NHSN AUR module page lists the validated products. A hospital that has an exclusion today often loses it at the next EHR upgrade, which is when the purchase usually lands on the stewardship pharmacist's desk.

The detailed reporting mechanics, including the resistance half of AUR and the vendor validation lists, are covered in NHSN AUR reporting software compared. This article stays on the use side and on what a team does with the numbers once they exist.

Antimicrobial use software options compared

The table comes from each vendor's published material and the pricing pages we keep for Sentri7 and VigiLanz. KLAS ratings and the alerting side of the same platforms are compared in Sentri7 vs TheraDoc vs VigiLanz.

Antimicrobial use software for US hospitals, by what it tracks and how it is sold.
Option Days of therapy and SAAR Data it needs Resistance reporting Price published Best for
Epic stewardship module Yes, with NHSN AU export Epic eMAR, already in place Partly, depends on local build No, part of the Epic contract Epic hospitals with analyst time
Oracle Health (Cerner) and MEDITECH Yes, AU reporting options Native eMAR Partly, depends on build No, part of the EHR contract Hospitals on those EHRs
Sentri7 (Wolters Kluwer) Yes, NHSN validated EHR, eMAR and lab interfaces Yes No, quoted after demo Systems that want alerts and reporting together
VigiLanz (Inovalon) Yes, NHSN reporting EHR, eMAR and lab interfaces Yes No, implementation plus annual license Hospitals buying one platform for stewardship and infection control
TheraDoc (Premier) Yes, NHSN reporting EHR, eMAR and lab interfaces Yes No, sold through Premier Premier members
Antimicrobe No Lab CSV export only Yes, antibiogram, unit cuts, quarterly trends, MDRO watch Yes, $249 Lab or $749 Stewardship a month Teams whose use reporting is covered but resistance is still a spreadsheet

How much does antimicrobial use software cost?

There is no list price for any of the use-tracking options. EHR modules are priced inside the EHR agreement, sometimes as an add-on license plus analyst build hours. Surveillance platforms charge a one-time implementation fee and an annual license sized by beds or facilities and modules, and the interface work is often the largest line for a small hospital because the EHR vendor may also charge to open the feeds. Ask every vendor for the AU module alone and for the bundle, in writing.

What a falling days of therapy number cannot tell you

Use software answers how much. It does not answer whether the drugs still work. A stewardship program that cuts carbapenem days by a third has done something real, but the committee will ask the next question at once: did resistance move? That answer comes from the laboratory, not the eMAR, as a cumulative antibiogram and a resistance trend by unit and quarter. The CDC Core Elements treat the two as a pair, tracking use and tracking resistance, and an accreditation surveyor will ask to see both.

In many community hospitals the use half is now automated because CMS forced the purchase, while the resistance half is still a spreadsheet rebuilt once a year. The result is a quarterly report with a precise days of therapy chart next to an antibiogram that is 14 months old.

A worked example for a 160 bed hospital

A 160 bed hospital records 41,000 days present a year. In the year before an intervention its medical ICU used meropenem on 1,380 days out of 6,900 days present, 200 days of therapy per 1,000 days present. After an ICU guideline that moved empiric sepsis therapy to cefepime unless the patient had a prior resistant organism, meropenem fell to 860 days, 125 per 1,000. Cefepime rose from 690 to 1,170 days, 100 to 170 per 1,000. The use software shows all of that within a month of the change.

What it cannot show is whether cefepime was the right default. That depends on the unit's gram-negative susceptibility. If the ICU Pseudomonas aeruginosa isolates are 112 of 131 cefepime susceptible, 85.5 percent, and the ICU Enterobacterales are 241 of 268 susceptible, 89.9 percent, the guideline stands. If those numbers came from a hospital-wide table dominated by outpatient urine, the committee is approving a guideline on the wrong denominator. These figures are illustrative arithmetic, not data from a customer.

Pairing use software with resistance reporting

If the use side is already handled by your EHR or a platform, the resistance side does not need another interface. Antimicrobe reads the susceptibility export your laboratory system already produces, applies the CLSI M39 first isolate per patient rule, suppresses any cell under 30 isolates and builds the cumulative antibiogram by specimen source and period on the Lab plan at $249 a month. The Stewardship plan at $749 a month adds cuts by unit and syndrome, quarter by quarter resistance trends and MDRO watch, so the ICU table in the example above comes from the same upload as the hospital one.

It does not count days of therapy, read the eMAR or submit to NHSN. The split between the two jobs is laid out with a six option table on antibiotic surveillance software for use and resistance tracking. For the organism tables that most often follow a use intervention, see Pseudomonas antibiogram software and E. coli antibiogram software, and for unit level tables, ICU antibiogram software.

Questions to ask before you buy antimicrobial use software

  • Is the AU output validated by the CDC for NHSN submission, and in which version?
  • Does it count from eMAR or barcode administration data, and which of our locations map to NHSN location types?
  • Can we see days of therapy by unit within a month of a guideline change, without an analyst request?
  • Is the price for AU alone available, or only as part of a platform bundle?
  • Where will the resistance numbers that sit next to the use chart come from, and how old will they be?

Who buys this

The reader who buys from us is the stewardship pharmacist or infection prevention lead whose use reporting is now automated, or about to be, and whose antibiogram and MDRO counts are still built by hand. They can start on the Lab or Stewardship plan with one CSV export and have current resistance tables before the next committee meeting. Small hospitals weighing the whole stewardship budget can read antibiotic stewardship software cost for a small hospital.


Related on this site: antibiotic surveillance software for use and resistance, NHSN AUR reporting software compared, antibiotic stewardship metrics.

Next step

Put current resistance data next to your use numbers

Set the filters, watch the numbers move, and read the rules that produced them. The builder is open on the homepage, with no account and no upload.

Your file is parsed in your browser and never uploaded. No card required.